A phase II trial of erlotinib as maintenance treatment after concurrent chemoradiotherapy in stage III non-small-cell lung cancer (NSCLC): A Galician Lung Cancer Group (GGCP) study

1. Casal Rubio, J.
2. Fírvida-Pérez, J.L.
3. Lázaro-Quintela, M.
4. Barón-Duarte, F.J.
5. Alonso-Jáudenes, G.
6. Santomé, L.
7. Afonso-Afonso, F.J.
8. Amenedo, M.
9. Huidobro, G.
10. Campos-Balea, B.
11. López-Vázquez, M.D.
12. Vázquez, S.